Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANBESURE: Bemiparin for VTE Prophylaxis in Cancer Surgery
NCT00219973Phase 3Completed
- Sponsor
- Laboratorios Farmacéuticos ROVI
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of bemiparin in venous thromboembolism (VTE), sponsored by Laboratorios Farmacéuticos ROVI. Started May 2005; status: completed.
02
Drugs
bemiparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00219973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219973.